Teflutixol
| Teflutixol_structure.png | |
Teflutixol is a phenothiazine derivative that has been studied for its potential use as an antipsychotic medication. It belongs to the class of typical antipsychotics, which are primarily used to manage psychosis, including schizophrenia and bipolar disorder.
Pharmacology[edit | edit source]
Teflutixol acts primarily as a dopamine receptor antagonist, particularly targeting the D2 receptors in the brain. This action is thought to be responsible for its antipsychotic effects. By blocking dopamine receptors, teflutixol can help reduce the symptoms of psychosis, such as hallucinations and delusions.
Mechanism of Action[edit | edit source]
The mechanism of action of teflutixol involves the inhibition of dopamine transmission in the mesolimbic pathway, which is associated with the positive symptoms of schizophrenia. Additionally, it may have effects on other neurotransmitter systems, including serotonin and norepinephrine, which could contribute to its therapeutic effects and side effect profile.
Clinical Use[edit | edit source]
Teflutixol has been investigated in clinical trials for its efficacy and safety in treating psychotic disorders. However, as of the latest updates, it has not been widely adopted in clinical practice, and further studies are needed to fully establish its therapeutic potential and safety profile.
Side Effects[edit | edit source]
Like other typical antipsychotics, teflutixol may cause a range of side effects, including:
- Extrapyramidal symptoms (EPS) such as tremors, rigidity, and bradykinesia
- Tardive dyskinesia, a potentially irreversible condition characterized by repetitive, involuntary movements
- Sedation
- Weight gain
- Anticholinergic effects such as dry mouth, constipation, and blurred vision
Research and Development[edit | edit source]
Research on teflutixol is ongoing, with studies focusing on its pharmacokinetics, optimal dosing regimens, and long-term safety. The development of teflutixol is part of a broader effort to improve the treatment options available for individuals with severe mental illnesses.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
